SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-303786
Filing Date
2023-12-27
Accepted
2023-12-27 13:05:00
Documents
12
Period of Report
2023-12-27
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d615272d8k.htm   iXBRL 8-K 26824
  Complete submission text file 0001193125-23-303786.txt   145914

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rprx-20231227.xsd EX-101.SCH 2858
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rprx-20231227_lab.xml EX-101.LAB 17237
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rprx-20231227_pre.xml EX-101.PRE 10818
6 EXTRACTED XBRL INSTANCE DOCUMENT d615272d8k_htm.xml XML 3455
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39329 | Film No.: 231516626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)